TickerGuard
Buy Day today: Neutral (58) Mixed market breadth · no major macro event
GKOS

Glaukos Corp

Healthcare · Medical Devices

164.00$ +0.2% vs. previous close Closing price · As of: Oct 5, 2026

Statements

Balance Sheet

Glaukos Corp (GKOS) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 921 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet GKOS
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
129 134 138 146 153 166 163 171 191 207 228 302 307 818 780 996 995 1,006 1,023 1,044 1,064 1,129 1,052 1,031 1,008 1,074 973 957 949 1,007 933 920 927 975 966 987 999 893 893 921
115 120 124 131 137 149 147 155 175 177 184 201 209 263 231 453 454 469 474 491 502 486 491 471 449 444 416 401 400 395 389 384 397 450 445 436 455 475 486 516
5.0 6.5 8.6 13 19 25 16 25 37 30 34 40 40 62 54 267 81 97 97 118 113 101 106 103 104 120 76 95 109 93 42 68 100 170 114 101 98 91 104 114
94 96 99 104 109 119 114 120 138 140 145 150 153 174 164 395 388 404 407 419 429 414 415 391 362 353 318 304 301 295 273 262 262 319 299 275 274 279 277 286
12 14 14 17 17 17 18 17 20 19 21 22 24 38 29 27 33 36 37 38 35 33 35 36 35 36 38 39 39 40 47 51 56 61 72 83 99 109 120 139
6.5 6.8 7.5 8.4 9.0 11 13 14 14 13 13 14 13 43 28 21 20 16 15 18 20 23 25 28 34 38 40 39 40 42 50 56 60 58 59 65 64 64 62 59
7.0 7.6 7.8 8.7 11 12 12 12 12 19 20 20 20 22 23 23 23 24 43 124 139 146 75 155 161 94 98 103 175 – – – – – – – – – – –
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 – – – – 66 66 66 66 66 66 66 66 66 66 66 66 66 66 66 66 66 66 66 66 66 66 67 67 67 67 67
7.5 6.6 6.0 5.0 4.1 3.1 2.2 1.3 0.4 – – – – 383 376 370 364 358 351 345 339 333 327 320 314 308 302 295 289 283 282 276 269 263 258 270 264 142 133 127
19 17 15 20 21 28 20 23 27 33 43 114 117 145 138 333 333 338 433 459 463 542 455 469 460 544 464 468 471 545 483 255 258 208 202 222 230 237 222 238
19 17 15 19 20 27 19 20 25 30 27 31 33 58 51 55 47 50 336 349 63 63 56 70 61 72 62 64 67 74 72 70 72 75 69 79 88 101 89 102
3.0 – – – – – – – – – – 1.5 1.9 2.4 2.4 – 1.5 1.2 279 279 1.2 1.0 – 0.5 0.2 0.4 1.4 2.1 1.9 1.3 2.2 2.3 – – – – – – – –
4.7 3.0 3.9 6.0 3.6 6.2 4.8 3.6 5.6 6.3 5.7 5.1 3.5 5.8 13 9.2 6.8 4.4 8.6 7.0 8.5 7.3 8.0 21 11 14 12 8.6 10 13 13 12 11 13 16 14 20 25 19 19
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 – 12 – – – – 184 187 189 – – 280 280 280 281 281 281 282 282 282 283 283 57 57 – – – – – – –
110 117 123 126 132 138 143 149 163 174 185 188 190 673 641 662 662 667 590 584 601 587 598 562 549 530 509 489 478 462 451 665 669 767 764 765 770 656 671 682
-192 -192 -191 -195 -193 -192 -195 -200 -207 -205 -206 -213 -226 -190 -244 -284 -299 -310 -332 -350 -343 -365 -360 -405 -433 -464 -499 -532 -562 -599 -640 -690 -712 -745 -764 -783 -799 -933 -953 -971
37 37 38 34 38 37 35 35 36 40 36 36 37 43 44 44 45 45 46 46 49 47 50 47 48 48 48 48 49 49 50 51 55 56 57 57 57 58 58 58

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?